Immune function of patients receiving recombinant?human interleukin-6 (IL-6) in a phase I clinical study:? induction of C-reactive protein and IgE and inhibition?of natural killer and lymphokine-activated killer cell activity
1994 ◽
Vol 38
(2)
◽
pp. 119-126
◽
Keyword(s):
Phase I
◽
Keyword(s):
1998 ◽
Vol 5
(1)
◽
pp. 54A-54A
◽
1991 ◽
Vol 29
(3)
◽
pp. 267
◽
1996 ◽
Vol 67
(1)
◽
pp. 67-70
◽
1981 ◽
Vol 1
(2)
◽
pp. 253-262
◽